Abstract
Objective: To show the computed tomography (CT) usefulness after treatment with transcatheter arterial quimioembolization and radiofrequency ablation of hepatocellular carcinoma. Material and methods: In a period between march 2006 to april 2008 a total of 90 patient presenting 148 nodular lesions with diagnosis of hepatocellular carcinoma were controlled with triphasic CT. All the lesions were treated with minimally invasive procedure. For the treatment, the patients were classified in two groups following Milan criteria. The first group, constituted by 75 patients with 109 nodules, was treated with quimioembolization. The second group, of 15 patients with 25 nodules, was treated with radiofrequency ablation. In our population, a subgroup of 10 patients was treated with both methods. Results: Of 90 patients after CT control on a month, 3 months and for each 3 months during 2 years, on 63 cases (70%) was observed homogeneous accumulation of iodized oil, partial defect without enhancement or absence of enhancement on treated lesions. In these patients a new treatment after initial one was not performed. The remaining 27 patients (30%) underwent new treatment because we founded partial defect or absence of iodized oil with enhancement or peripheral enhancement on arterial phase in treated lesions. In this last
More>>
Kozima, Shigeru;
Larranaga, Nebil;
Wulfson, Gabriela;
[1]
Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)];
Eisele, Guillermo;
[2]
Ridruejo, Ezequiel;
Mando, Oscar;
[3]
Perazzo, Florencia
[4]
- Servicio de Diagnostico por Imagenes Hospital General de Agudos 'Cosme Argerich', CABA, Buenos Aires (Argentina)
- Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)
- Seccion de Hepatologia. Departamento de Medicina, CEMIC, Buenos Aires (Argentina)
- Seccion Oncologia. Departamento de Medicina, CEMIC, Buenos Aires (Argentina)
Citation Formats
Kozima, Shigeru, Larranaga, Nebil, Wulfson, Gabriela, Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)], Eisele, Guillermo, Ridruejo, Ezequiel, Mando, Oscar, and Perazzo, Florencia.
Hepatocellular carcinoma: computed tomography assessment after invasive treatment;Hepatocarcinoma: Evaluacion con tomografia computada luego del tratamiento intervencionista.
Argentina: N. p.,
2008.
Web.
Kozima, Shigeru, Larranaga, Nebil, Wulfson, Gabriela, Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)], Eisele, Guillermo, Ridruejo, Ezequiel, Mando, Oscar, & Perazzo, Florencia.
Hepatocellular carcinoma: computed tomography assessment after invasive treatment;Hepatocarcinoma: Evaluacion con tomografia computada luego del tratamiento intervencionista.
Argentina.
Kozima, Shigeru, Larranaga, Nebil, Wulfson, Gabriela, Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)], Eisele, Guillermo, Ridruejo, Ezequiel, Mando, Oscar, and Perazzo, Florencia.
2008.
"Hepatocellular carcinoma: computed tomography assessment after invasive treatment;Hepatocarcinoma: Evaluacion con tomografia computada luego del tratamiento intervencionista."
Argentina.
@misc{etde_21385536,
title = {Hepatocellular carcinoma: computed tomography assessment after invasive treatment;Hepatocarcinoma: Evaluacion con tomografia computada luego del tratamiento intervencionista}
author = {Kozima, Shigeru, Larranaga, Nebil, Wulfson, Gabriela, Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)], Eisele, Guillermo, Ridruejo, Ezequiel, Mando, Oscar, and Perazzo, Florencia}
abstractNote = {Objective: To show the computed tomography (CT) usefulness after treatment with transcatheter arterial quimioembolization and radiofrequency ablation of hepatocellular carcinoma. Material and methods: In a period between march 2006 to april 2008 a total of 90 patient presenting 148 nodular lesions with diagnosis of hepatocellular carcinoma were controlled with triphasic CT. All the lesions were treated with minimally invasive procedure. For the treatment, the patients were classified in two groups following Milan criteria. The first group, constituted by 75 patients with 109 nodules, was treated with quimioembolization. The second group, of 15 patients with 25 nodules, was treated with radiofrequency ablation. In our population, a subgroup of 10 patients was treated with both methods. Results: Of 90 patients after CT control on a month, 3 months and for each 3 months during 2 years, on 63 cases (70%) was observed homogeneous accumulation of iodized oil, partial defect without enhancement or absence of enhancement on treated lesions. In these patients a new treatment after initial one was not performed. The remaining 27 patients (30%) underwent new treatment because we founded partial defect or absence of iodized oil with enhancement or peripheral enhancement on arterial phase in treated lesions. In this last group, 16 treated patients (17.7%) had new nodular enhancement on the remaining hepatic parenquimal. Conclusion: The CT unenhanced and the arterial phase on a month and for each 3 months, allow monitoring the effectiveness, residual disease and/or relapse of hepatocellular carcinoma after minimally invasive treatment. (authors);Objetivo: Mostrar la utilidad de la tomografia computada trifasica (TCT) luego del tratamiento con quimioembolizacion y ablacion por radiofrecuencia (RF) del hepatocarcinoma (HCC). Material y metodos: En un periodo comprendido entre marzo de 2006 y abril de 2008 se controlaron con TCT 90 pacientes que presentaron 148 lesiones nodulares y diagnostico de hepatocarcinoma; todas fueron tratadas en forma minimamente invasiva. Para el tratamiento se dividio a los pacientes en dos grupos siguiendo el criterio de Milan. El primer grupo, constituido por 75 pacientes con 109 nodulos, fue tratado con quimioembolizacion. El segundo grupo, de 15 pacientes y 25 nodulos, fue tratado con ablacion por radiofrecuencia. Dentro de nuestra poblacion, hubo un subgrupo de 10 pacientes (14 nodulos) que se trato con ambos metodos. Resultados: De los 90 pacientes tratados, luego de los controles con TC realizados a un mes, 3 meses y cada 3 meses durante dos anios, en 63 casos (70%) se observo acumulacion homogenea del lipiodol, defecto parcial sin realce o ausencia de realce en la lesion tratada. A estos no se les realizo nuevo procedimiento luego del tratamiento inicial. En los 27 pacientes restantes (30%), se practico un nuevo tratamiento por visualizarse defecto parcial o ausencia del lipiodol con realce o realce periferico en la fase arterial de la lesion tratada. En este ultimo grupo, 16 pacientes tratados (17,7%) tuvieron nuevo realce nodular en el parenquima hepatico restante. Conclusion: La TC en las fases sin contraste y arterial, a un mes y cada 3 meses, permite evaluar la efectividad, enfermedad residual y/o la recaida del hepatocarcinoma luego del tratamiento minimamente invasivo. (autores)}
journal = []
issue = {4}
volume = {72}
place = {Argentina}
year = {2008}
month = {Jul}
}
title = {Hepatocellular carcinoma: computed tomography assessment after invasive treatment;Hepatocarcinoma: Evaluacion con tomografia computada luego del tratamiento intervencionista}
author = {Kozima, Shigeru, Larranaga, Nebil, Wulfson, Gabriela, Departamento de Imagenes, CEMIC, Buenos Aires (Argentina)], Eisele, Guillermo, Ridruejo, Ezequiel, Mando, Oscar, and Perazzo, Florencia}
abstractNote = {Objective: To show the computed tomography (CT) usefulness after treatment with transcatheter arterial quimioembolization and radiofrequency ablation of hepatocellular carcinoma. Material and methods: In a period between march 2006 to april 2008 a total of 90 patient presenting 148 nodular lesions with diagnosis of hepatocellular carcinoma were controlled with triphasic CT. All the lesions were treated with minimally invasive procedure. For the treatment, the patients were classified in two groups following Milan criteria. The first group, constituted by 75 patients with 109 nodules, was treated with quimioembolization. The second group, of 15 patients with 25 nodules, was treated with radiofrequency ablation. In our population, a subgroup of 10 patients was treated with both methods. Results: Of 90 patients after CT control on a month, 3 months and for each 3 months during 2 years, on 63 cases (70%) was observed homogeneous accumulation of iodized oil, partial defect without enhancement or absence of enhancement on treated lesions. In these patients a new treatment after initial one was not performed. The remaining 27 patients (30%) underwent new treatment because we founded partial defect or absence of iodized oil with enhancement or peripheral enhancement on arterial phase in treated lesions. In this last group, 16 treated patients (17.7%) had new nodular enhancement on the remaining hepatic parenquimal. Conclusion: The CT unenhanced and the arterial phase on a month and for each 3 months, allow monitoring the effectiveness, residual disease and/or relapse of hepatocellular carcinoma after minimally invasive treatment. (authors);Objetivo: Mostrar la utilidad de la tomografia computada trifasica (TCT) luego del tratamiento con quimioembolizacion y ablacion por radiofrecuencia (RF) del hepatocarcinoma (HCC). Material y metodos: En un periodo comprendido entre marzo de 2006 y abril de 2008 se controlaron con TCT 90 pacientes que presentaron 148 lesiones nodulares y diagnostico de hepatocarcinoma; todas fueron tratadas en forma minimamente invasiva. Para el tratamiento se dividio a los pacientes en dos grupos siguiendo el criterio de Milan. El primer grupo, constituido por 75 pacientes con 109 nodulos, fue tratado con quimioembolizacion. El segundo grupo, de 15 pacientes y 25 nodulos, fue tratado con ablacion por radiofrecuencia. Dentro de nuestra poblacion, hubo un subgrupo de 10 pacientes (14 nodulos) que se trato con ambos metodos. Resultados: De los 90 pacientes tratados, luego de los controles con TC realizados a un mes, 3 meses y cada 3 meses durante dos anios, en 63 casos (70%) se observo acumulacion homogenea del lipiodol, defecto parcial sin realce o ausencia de realce en la lesion tratada. A estos no se les realizo nuevo procedimiento luego del tratamiento inicial. En los 27 pacientes restantes (30%), se practico un nuevo tratamiento por visualizarse defecto parcial o ausencia del lipiodol con realce o realce periferico en la fase arterial de la lesion tratada. En este ultimo grupo, 16 pacientes tratados (17,7%) tuvieron nuevo realce nodular en el parenquima hepatico restante. Conclusion: La TC en las fases sin contraste y arterial, a un mes y cada 3 meses, permite evaluar la efectividad, enfermedad residual y/o la recaida del hepatocarcinoma luego del tratamiento minimamente invasivo. (autores)}
journal = []
issue = {4}
volume = {72}
place = {Argentina}
year = {2008}
month = {Jul}
}